Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Return on Assets [ROA] (2009 - 2026)

Updated

Elite Pharmaceuticals' Return on Assets [ROA] was 42.46% in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 30.35 percentage points from 12.11% a year earlier and up 1.69 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Return on Assets [ROA] at Elite Pharmaceuticals came in at 38.24%, up 43.13 percentage points from FY2025.

  • Return on Assets [ROA] shows a five-year change of +3713.06 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Assets [ROA] was -4.89% in FY2025 (-37.24 pp), 32.35% in FY2024 (+22.98 pp), 9.37% in FY2023 (-16.85 pp) and 26.22% in FY2022 (+3701.04 pp).
  • The fiscal Q2 2027 figure marks the highest quarterly Return on Assets [ROA] since fiscal Q1 2016.
  • Compared with a year earlier, Return on Assets [ROA] has increased for five straight quarters, with an average year-over-year change of +11.27 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q4 2022 (a gain of 3446.89 percentage points); the worst was fiscal Q3 2022 (a drop of 3023.78 percentage points).
  • Per Business Quant data, ELTP's Return on Assets [ROA] in the three fiscal quarters before Q2 2027 was 40.77% (Q1 2027), 33.90% (Q4 2026) and 35.56% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 8.08%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 7.32%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.87%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.36%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 9.80%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -7.67%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 2.00%
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 42.46%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 42.46%
Jun 30, 2026 40.77%
Mar 31, 2026 33.90%
Dec 31, 2025 35.56%
Sep 30, 2025 12.11%
Jun 30, 2025 -10.50%
Mar 31, 2025 -4.70%
Dec 31, 2024 -20.06%
Sep 30, 2024 -7.22%
Jun 30, 2024 22.88%
Mar 31, 2024 25.44%
Dec 31, 2023 21.39%
Sep 30, 2023 30.40%
Jun 30, 2023 10.06%
Mar 31, 2023 7.61%
Dec 31, 2022 14.01%
Sep 30, 2022 13.27%
Jun 30, 2022 16.37%
Mar 31, 2022 23.97%
Dec 31, 2021 -3,000.66%
API Access

Elite Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY